GRSD vs SRAD vs SPT Stock Comparison

Grandstand, Sportradar Group AG and Sprout Social Prices as of Oct 26, 2026 Peers: Industry group
GRSD GRANDSTAND Ltd
$1.17 -25.5% 1M -84.5% 1Y
Market cap
$41.33M
P/E
–
Revenue (TTM)
$163.42M
Div. yield
–
Marketing Software Technology
1 win
SRAD Sportradar Group AG
$12.60 -4.8% 1M -53.4% 1Y
Market cap
$12.65B
P/E
634.4x
Revenue (TTM)
$1.62B
Div. yield
–
Data Infrastructure Technology
6 wins
SPT Sprout Social, Inc.
$12.76 +33.8% 1M +13.4% 1Y
Market cap
$663.50M
P/E
–
Revenue (TTM)
$481.82M
Div. yield
–
Marketing Software Technology
3 wins

Head to Head

10 decided of 12

Sportradar Group AG leads on 6 of the 12 questions below (Sportradar Group AG 6, Sprout Social 3, Grandstand 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionGRSDSRADSPTLeader
Larger companyMarket capitalisation $41.33M $12.65B $663.50M SRAD
Cheaper on earningsLower P/E, profitable companies only -1.1x 634.4x -22.5x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 10.6x 48.5x 10.6x SPT
Faster revenue growthRevenue growth, trailing twelve months +10.7% +24.7% +11.8% SRAD
More profitableNet margin, trailing twelve months -23.1% 1.2% -6.1% SRAD
Better return on capitalReturn on invested capital -10.9% -8.6% -11.2% SRAD
Less leveragedLower net debt / EBITDA -10.9x 1.4x -7.3x GRSD
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -84.5% -53.4% +13.4% SPT
Better 5-year returnAnnualised price return, 5 years -38.9%/yr -9.0%/yr -36.1%/yr SRAD
Less volatileAnnualised volatility, 1 year 80.7% 56.6% 66.4% SRAD
Higher overall scoreMean of the five percentile scores vs peers 36/100 59/100 63/100 SPT

Percentile Scorecard

GRSDSRADSPT

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisGRSDSRADSPT
Valuation 70 #31 of 102 77 #29 of 124 67 #34 of 102
Growth 10 #88 of 98 63 #43 of 113 79 #21 of 98
Profitability 36 #61 of 95 71 #33 of 110 42 #56 of 95
Financial Health 26 #81 of 109 56 #57 of 129 65 #39 of 109
Shareholder Returns – 30 #47 of 67 –
Overall 36 59 63
  • GRSD ranked among 115 companies in Business Applications
  • SRAD ranked among 137 companies in Infrastructure Software
  • SPT ranked among 115 companies in Business Applications

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodGRSDSRADSPTSPY
1 month -25.5%-4.8%+33.8% -0.8%
3 months -40.0%-14.2%+53.4% +3.5%
6 months -69.3%-9.5%+112.3% +7.0%
Year to date -78.6%-47.0%+13.2% +12.2%
1 year -84.5%-53.4%+13.4% +13.0%
3 years -90.8%+44.0%-69.6% +86.3%
3 years, per year -54.8%+12.9%-32.8% +23.1%
5 years -91.4%-37.5%-89.3% +68.6%
5 years, per year -38.9%-9.0%-36.1% +11.0%

Risk

MeasureGRSDSRADSPTSPY
Volatility, 1Y 80.7%56.6%66.4% 12.7%
Downside volatility, 1Y 96.6%64.4%64.5% 12.7%
Beta vs S&P 500, 1Y 1.690.570.80 1.00
Return / volatility, 1Y -1.05-0.940.20 1.02
Max drawdown, 5Y -93.0%-69.0%-96.5% -25.4%
From 52-week high -84.8%-53.5%-2.7% -1.8%
52-week high $7.68$27.11$13.11 $779.14
52-week low $1.17$11.56$4.99 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleGRSDSRADSPT
P/E now vs peer median -1.1xmedian 28.8x 655.2xmedian 38.1x -23.2xmedian 28.8x
P/S now vs peer median 0.3xmedian 2.8x 2.4xmedian 4.3x 1.6xmedian 2.8x
EV/EBITDA now vs peer median -14.8xmedian 17.7x -14.4xmedian 35.4x 57.1xmedian 17.7x
P/FCF now vs peer median 10.9xmedian 15.8x 7.7xmedian 27.1x 15.4xmedian 15.8x
P/B now vs peer median 0.4xmedian 3.2x 4.4xmedian 3.4x 3.4xmedian 3.2x
PEG now vs peer median 0.01median 0.85 22.63median 1.27 -1.30median 0.85

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsGRSDSRADSPT
Revenue $163.42M $1.62B $481.82M
Gross profit $141.10M – $373.15M
Operating income -$24.88M – -$28.45M
Net income -$34.80M $19.94M -$29.55M
Free cash flow $3.77M $510.26M $50.36M
R&D – $44.37M $107.05M
EPS (diluted) $-1.06 $64,328.88 $-0.49
Cash & equivalents $8.81M $286.82M $119.93M
Total debt $122.33M $49.28M $32.50M
Shares (diluted) 35.48M 310.00 60.24M
Enterprise value $942.25K $10.94B $246.04M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricGRSDSRADSPT
P/E -1.1x 655.2x -23.2x
P/FCF 10.9x 7.7x 15.4x
P/Operating cash flow 11.2x 7.8x 14.3x
P/S 0.3x 2.4x 1.6x
P/B 0.4x 4.4x 3.4x
P/Tangible book 0.4x 4.4x 4.0x
EV/EBITDA -14.8x -14.4x 57.1x
EV/EBIT -6.2x -42.7x -24.1x
EV/Revenue 0.9x 2.2x 1.4x
EV/FCF 41.0x 7.0x 13.6x
EV/Operating cash flow 42.2x 7.2x 12.7x
PEG (3Y EPS CAGR) 0.01 22.63 -1.30

Growth

14 metrics
MetricGRSDSRADSPT
Revenue growth (1Y) 10.7% 24.7% 11.8%
Revenue CAGR (3Y) 20.4% 23.9% 18.5%
Gross profit growth (1Y) 1.6% – 11.6%
Gross profit CAGR (3Y) 15.9% – 18.6%
Operating income growth (1Y) -264.5% – 47.4%
Operating income CAGR (3Y) -69.2% – 19.4%
Net income growth (1Y) -304.4% -83.5% 46.0%
Net income CAGR (3Y) -91.4% 51.8% 15.6%
EPS growth (1Y) -265.6% -94.7% 47.7%
EPS CAGR (3Y) -105.4% 28.9% 17.9%
Operating cash flow growth (1Y) -89.4% 15.0% 48.6%
Operating cash flow CAGR (3Y) -46.2% 30.5% 42.6%
Free cash flow growth (1Y) -89.4% 15.7% 54.2%
Free cash flow CAGR (3Y) -49.5% 30.7% 43.6%

Profitability

14 metrics
MetricGRSDSRADSPT
Gross margin 86.3% – 77.4%
EBITDA margin -6.4% -15.4% 2.5%
Operating margin -15.2% – -5.9%
Pretax margin -21.6% 1.4% -6.0%
Net margin -23.1% 1.2% -6.1%
FCF margin 2.3% 31.6% 10.5%
Operating cash flow margin 2.2% 31.0% 11.2%
Return on equity -32.9% 2.1% -13.3%
Return on assets -12.1% 0.7% -5.7%
Return on invested capital -10.9% -8.6% -11.2%
Return on capital employed -10.8% -3.5% -10.2%
Asset turnover 0.6x 0.5x 0.9x
Cash conversion (OCF / net income) -0.1x 25.1x -1.8x
Stock comp / revenue 4.1% 4.2% 15.1%

Financial Health

11 metrics
MetricGRSDSRADSPT
Debt / assets 43.0% 0.4% 6.2%
Debt / equity 1.2x 0.0x 0.1x
Net debt / EBITDA -10.9x 1.4x -7.3x
Debt / FCF 32.5x 0.0x 0.6x
Liabilities / assets 63.2% 69.5% 56.2%
Equity / assets 36.8% 30.5% 43.8%
Interest coverage -5.5x -0.8x -9.9x
Current ratio 0.6x 1.0x 1.0x
Quick ratio 0.6x 0.9x 0.8x
Cash ratio 0.2x 0.6x 0.5x
Altman Z-score 0.51 1.78 1.24

Shareholder Returns

7 metrics
MetricGRSDSRADSPT
Dividend yield – – –
Net buyback yield – -1.0% –
Shareholder yield – -1.0% –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusGRSDSRADSPT
Forward P/E 10.6xFY2026 48.5xFY2026 10.6xFY2026
EPS, next fiscal year $0.11FY2026 $0.26FY2026 $1.20FY2026
EPS growth, next FY – -27.8%FY2026 +46.3%FY2026
EPS growth, the year after +336.4% +100.0% +22.5%
Revenue, next fiscal year $173.87MFY2026 $1.65BFY2026 $472.24MFY2026
Revenue growth, next FY +5.1%FY2026 +8.4%FY2026 +3.2%FY2026
Revenue growth, the year after +5.3% +10.8% +16.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersGRSDSRADSPT
Held by institutions – 17.8% 93.3%
Institutions holding – 151 192
Change in shares held, QoQ – -2.8% +4.1%
Institutions buying – 88 114
Institutions selling – 42 57
Buyers to sellers – 2.10 2.00

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

GRSDSRADSPT
GRSD 1.00 0.17 0.20
SRAD 0.17 1.00 0.19
SPT 0.20 0.19 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, GRSD, SRAD and SPT?

Sportradar Group AG (SRAD) is the largest by market capitalisation: Grandstand (GRSD) $41.33M, Sportradar Group AG (SRAD) $12.65B, Sprout Social (SPT) $663.50M.

Which company is growing faster?

Sportradar Group AG (SRAD) grew revenue fastest over the trailing twelve months: Grandstand (GRSD) +10.7%, Sportradar Group AG (SRAD) +24.7%, Sprout Social (SPT) +11.8%.

Which company is more profitable?

Sportradar Group AG (SRAD) has the highest net margin (Grandstand (GRSD) -23.1%, Sportradar Group AG (SRAD) 1.2%, Sprout Social (SPT) -6.1%). On return on invested capital, Sportradar Group AG (SRAD) leads (Grandstand (GRSD) -10.9%, Sportradar Group AG (SRAD) -8.6%, Sprout Social (SPT) -11.2%).

Which stock has performed better?

Over the past year Sprout Social (SPT) returned the most: Grandstand (GRSD) -84.5%, Sportradar Group AG (SRAD) -53.4%, Sprout Social (SPT) +13.4%. Over five years, Sportradar Group AG (SRAD) compounded fastest (Grandstand (GRSD) -38.9%/yr, Sportradar Group AG (SRAD) -9.0%/yr, Sprout Social (SPT) -36.1%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Sportradar Group AG (SRAD) has been the steadiest (Grandstand (GRSD) 80.7%, Sportradar Group AG (SRAD) 56.6%, Sprout Social (SPT) 66.4%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, GRSD, SRAD and SPT?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Sportradar Group AG (SRAD) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.